JP Morgan Upgrades Varian Medical Systems to Overweight

Loading...
Loading...
JP Morgan has upgraded Varian Medical Systems
VAR
from Neutral to Overweight and has raised the price target from $66 to $75.
Market News and Data brought to you by Benzinga APIs
Posted In: UpgradesPrice TargetPre-Market OutlookAnalyst RatingsJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...